The site has now an additional 35 new freezers for ultra-low temperature (ULT) storage thanks to the increased site’s footprint to 31,000ft²
Catalent installs additional 35 new freezers for ULT storage at the site. (Credit: CDC on Unsplash)
US-based pharma company Catalent has completed the previously announced $2.2m expansion of its clinical supply facility in Singapore.
The investment has increased the site’s footprint to 31,000ft², which is equal to a 20% increase in floor space.
The expansion has enabled Catalent to install an additional 35 new freezers for ultra-low temperature (ULT) storage at the site.
Additionally, the funds have raised the facility’s capabilities to support larger packaging campaigns through the addition of specialised secondary packaging capabilities for ULT products.
According to the pharma company, the facility is now better equipped to handle biopharmaceuticals and advanced modalities, such as mRNA-based vaccines, and cell and gene therapies.
Catalent APAC Operations general manager Tracey Clare said: “The Singapore site was the first Catalent clinical supply facility in the Asia-Pacific region, and now serves as a strategic supply hub, shipping clinical materials with high reliability and speed to over 20 countries.
“This year marks the site’s 25-year anniversary, and through the investments and expansions we have made over that time, it is well positioned to support the needs of modern Asia-Pacific and global clinical trials.”
Catalent’s site in Singapore, in addition to its locations in China and Japan, provides a wide range of clinical supply services to the Asia-Pacific region.
These services include clinical supply management, comparator sourcing, Catalent’s FastChain demand-led supply solution, secondary packaging, storage, and international distribution, and clinical returns and destruction.
In 2018, Catalent announced the completion of a two-year, $4.6m expansion at this clinical supply facility. The investment provided more space for secondary packaging, doubled its ambient storage and quadrupled its cold storage capacity.
In December last year, the company completed the expansion project of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
As part of the project, the site increased its space by about 30,000ft² to install additional deep-frozen and refrigerated storage.